Veldona oral low dose natural interferon-alpha regulatory update

The FDA granted Orphan Drug designation to AMAR's Veldona to treat Behcet's disease, a chronic relapsing inflammatory disorder. AMAR expects to begin this year clinical testing of Veldona in the indic...